Related Experiment Video
Updated: Jun 3, 2026
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Adipose tissue dysfunction in polycystic ovary syndrome
Jennifer Villa1, Richard E Pratley
1Diabetes and Metabolism Translational Medicine Unit, University of Vermont College of Medicine, Colchester Research Facility, 110C, 208 South Park Street, Colchester, VT 05446, USA.
Current Diabetes Reports
|March 23, 2011
Summary
Polycystic ovary syndrome (PCOS) involves metabolic and endocrine issues in women, characterized by adipose tissue dysfunction. This dysfunction contributes to insulin resistance and metabolic syndrome features seen in PCOS patients.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Reproductive Health
Background:
- Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder in premenopausal women.
- PCOS is linked to infertility, insulin resistance, metabolic syndrome, and increased diabetes risk.
- Abdominal obesity in PCOS suggests underlying adipose tissue dysfunction.
Purpose of the Study:
- To investigate the role of adipose tissue dysfunction in the metabolic abnormalities associated with Polycystic Ovary Syndrome (PCOS).
- To examine the characteristics of adipose tissue in women with PCOS, including adipocyte size and function.
Main Methods:
- Analysis of adipose tissue characteristics in women with PCOS.
- Evaluation of adipocyte size (hypertrophy).
- Assessment of lipolysis and insulin action within adipose tissue.
- Examination of adipokine expression and secretion, including adiponectin.
Main Results:
- Adipose tissue in women with PCOS exhibits hypertrophic adipocytes.
- Impaired lipolysis and insulin action are observed in PCOS adipose tissue.
- Altered expression and secretion of key adipokines, such as adiponectin, are implicated in PCOS-related insulin resistance.
Conclusions:
- Adipose tissue dysfunction is central to the metabolic abnormalities seen in Polycystic Ovary Syndrome.
- Further research is needed to determine if these metabolic issues are primary or secondary to hyperandrogenism in PCOS.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...